GenScript is the world leader in biotechnology reagent and biologics service industry. Established in 2002 in New Jersey, the company was the first to commercialize gene synthesis and successfully establish fully integrated capabilities for peptide synthesis, protein expression and antibody development. GenScript also have integrated & innovative biologics CDMO platform to accelerate the process from target to market and drive innovation further to develop therapeutic antibody and cell therapy platforms. We provide Antibody Discovery, Development services including GMP plasmid and viral vectors. Our mission is making people and nature healthier through biotechnology.